Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-05 Sale | 2021-03-08 5:32 pm | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 274 | $18.56 | $5,085 | 102,196 (Direct) | View |
| 2021-02-26 Sale | 2021-03-01 5:48 pm | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 3,151 | $17.03 | $53,662 | 102,470 (Direct) | View |
| 2021-02-23 Sale | 2021-02-25 6:32 pm | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 425 | $19.21 | $8,164 | 105,621 (Direct) | View |
| 2021-01-27 Sale | 2021-01-29 5:15 pm | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 81 | $14.06 | $1,139 | 79,796 (Direct) | View |
| 2020-12-07 Sale | 2020-12-09 5:24 pm | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 274 | $13.97 | $3,828 | 79,877 (Direct) | View |
| 2020-11-24 Sale | 2020-11-25 5:29 pm | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 355 | $13.17 | $4,675 | 79,291 (Direct) | View |
| 2020-10-27 Sale | 2020-10-29 6:09 pm | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 68 | $11.34 | $771 | 79,646 (Direct) | View |
| 2020-09-08 Sale | 2020-09-10 6:14 pm | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 285 | $11.02 | $3,141 | 79,714 (Direct) | View |
| 2020-08-25 Sale | 2020-08-26 6:17 pm | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 379 | $14.14 | $5,359 | 79,999 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-04-22 Disposition | 2021-04-22 1:53 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 17,500 | $0 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:53 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 101,324 | $24.05 | 0 (Direct) | View |
| 2021-04-01 Tax Withholding | 2021-04-06 6:00 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 1,730 | $0 | 100,466 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 7:02 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 35,000 | $0 | 114,796 (Direct) | View |
Ownership | 2020-08-10 5:42 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 0 | $0 | 80,378 (Direct) | View |